We offer full outsourced management of cell and gene therapy treatments for health care payers. From patient management to data collection, analysis, reporting, and claims administration, we manage emerging therapy solutions.
A 40-year veteran in health care and managed care industries, Dave McLean brings extensive experience as a successful leader and executive. Dave is the founding CEO of Emerging Therapy Solutions, Inc (ETS). ETS serves the payer industry to provide complete outsource services to manage cell and gene therapy treatments. Dave most recently was Chairman/CEO of Medication Management Systems, Inc., a pharmaceutical care management company, that he sold to Genoa HealthCare in 2017. Previously Dave was CEO of NovoLogix, a medical pharmacy technology company, that he sold to CVS in 2013. Past roles include: CEO of RxHub, an electronic prescribing company; CEO of United Resource Networks at United Health Group, that managed organ and tissue transplants for 45 million payer lives; SVP American MedCenters, an HMO management company where he managed provider contracting, reinsurance subsidiary services, and PBM services.
Dave holds a BS in Pharmacy from Ohio State University and a PhD from the University of Minnesota.
Ms. Bute most recently served as Director, Business Development and Integration in the Health and Care Engagement Division at HealthPartners. Areas of responsibility included directing new business development, relationship management, geographic expansion of care coordination strategies in Iowa, Wisconsin, North and South Dakota, high cost case strategies, and enterprise wide affordability facilitation. All work focused on the triple AIM (Experience, quality and affordability) delivering a personalized, integrated and seamless experience for patients and members. She also has over ten years with UnitedHealth Group where she developed deep insight into high cost reinsurance strategies, program design, consumerist concepts, and development of nationally networked centers of excellence.
Ms. Bute is a graduate of the College of St. Catherine in Nursing and has been invited to speak nationally and is published.
A 20-year veteran in health care and managed care industries, Ashley Hume brings extensive experience leading multidisciplinary teams in both the provider and managed care spaces. Ashley serves as the Vice President of Operations for Emerging Therapy Solutions, Inc (ETS). ETS serves the payer industry to provide complete outsource services to manage cell and gene therapy treatments. Most recently, Ashley was Director of Provider Relations for Blue Cross and Blue Shield of Minnesota, focused on network management and provider relations. Previously, Ashley has lead Revenue Cycle operations for multiple specialty groups gaining significant expertise in prior authorization, claims and patient financial services; as well as third-party payor contracting, direct-to-employer contracting and physician services contracting. Ashley also served as Vice President of Operations for NovoLogix, a medical pharmacy technology company sold to CVS in 2013. Past roles include Director of Business Services for Fairview Southdale hospital as well as multiple consulting engagements related to software development for healthcare services.
Chairman, Managing Director at Telegraph Hill
Non-Executive Director at Trakcel
CEO at Emerging Therapy Solutions
CEO at Trakcel
Partner, Chief Operating Officer at Telegraph Hill
